Cytek Biosciences (CTKB) CEO pay: $3.6M actually paid in FY2025
$CTKB · Cytek Biosciences, Inc.Data through FY2025 — latest proxy filed 2026-04-28, checked for new filings 2026-08-21. Every number links to its source.
0.9× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
A negative figure is not pay returned. Compensation Actually Paid re-values unvested equity every year, so when a stock falls, the write-down on awards granted earlier can exceed everything granted that year. How CAP is calculated
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2021 | Same, peer group since FY2021 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $5.1M | $3.6M | $1.4M | $26.92 | $113.99 | — |
| 2024 | $6.1M | $4.4M | $1.0M | $34.59 | $85.43 | — |
| 2023 | $4.9M | $3.7M | $1.6M | $48.61 | $85.92 | -$12.7M |
| 2022 | $3.9M | $1.9M | $552,405 | $54.42 | $82.14 | $2.5M |
| 2021 | $4.8M | -$130,465 | $126,586 | $86.99 | $91.40 | $3.0M |
Frequently asked
How much did the CTKB CEO make in 2025?
$3,643,672 in Compensation Actually Paid (CAP) as Cytek Biosciences, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-28.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on CTKB: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary